0001567619-23-006555.txt : 20230712 0001567619-23-006555.hdr.sgml : 20230712 20230712092324 ACCESSION NUMBER: 0001567619-23-006555 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20230712 DATE AS OF CHANGE: 20230712 EFFECTIVENESS DATE: 20230712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SEN-JAM PHARMACEUTICAL INC. CENTRAL INDEX KEY: 0001802249 IRS NUMBER: 822750291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-486575 FILM NUMBER: 231083394 BUSINESS ADDRESS: STREET 1: 223 WALL STREET, #130 CITY: HUNTINGTON STATE: NY ZIP: 11743 BUSINESS PHONE: 201-400-8083 MAIL ADDRESS: STREET 1: 223 WALL STREET, #130 CITY: HUNTINGTON STATE: NY ZIP: 11743 FORMER COMPANY: FORMER CONFORMED NAME: SEN-JAM PHARMACEUTICAL LLC DATE OF NAME CHANGE: 20200204 D 1 primary_doc.xml X0708 D LIVE 0001802249 SEN-JAM PHARMACEUTICAL INC. 223 WALL STREET, #130 HUNTINGTON NY NEW YORK 11743 201-400-8083 DELAWARE None SEN-JAM PHARMACEUTICAL LLC Corporation true Jacqueline Iversen 223 Wall Street, #130 Huntington NY NEW YORK 11743 Executive Officer Ms. Iversen is the Secretary of the Issuer. James Iversen 223 Wall Street, # 130 Huntington NY NEW YORK 11743 Executive Officer Director Mr. Iversen is the Chief Executive Officer, President and Treasurer of the Issuer. He is also the sole Director of the Issuer. Pharmaceuticals Decline to Disclose 06c false 2023-04-22 false true true true Convertible Promissory Notes; Warrants to purchase shares of common stock. false 10000 10000000 80000 9920000 The total amount sold and number of investors reflects sales to only residents of the United States. false 2 0 0 0 false SEN-JAM PHARMACEUTICAL INC. /s/ James Iversen James Iversen President of the Issuer 2023-07-11